Lessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series
Authors:
- Mory KeïtaMKMory Keïta
- Fatoumata ContéFCFatoumata Conté
- Boubacar DialloBDBoubacar Diallo
- Dieudonné LufwaDLDieudonné Lufwa
- Jacques KatombaJKJacques Katomba
- René SnackenRSRené Snacken
- Raymond PallawoRPRaymond Pallawo
- Aminata TolnoATAminata Tolno
- Amadou Bailo DialloADAmadou Bailo Diallo
- Mamadou Harouna DjingareyMDMamadou Harouna Djingarey
- Lorenzo SubissiLSLorenzo Subissi
Open Access
- 24 April 2017
- journal article
- case report
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 304
Abstract
By the end of the 2013–2016 West African Ebola Virus Disease (EVD) outbreaks, a total of 3814 cases (probable and confirmed) and 2544 deaths were reported in Guinea. Clearly, surveillance activities aiming at stopping human-to-human transmission have been the breakthrough of EVD outbreak management, but their application has been at times easier said than done. This article presents five confirmed or probable EVD cases that arose in Conakry towards the end of the Guinea epidemic, which demonstrate flaws in surveillance and follow-up. For case 1, safe burial requirements were not followed. For cases 1 and 2, negative Polymerase Chain Reaction (PCR) results were interpreted as no infection. For the first case, the sample may have not been taken properly while for the second the disease was possibly at its early stage. Case 3 was stopped at a border health checkpoint and despite her high temperature she was allowed to continue the bus journey. For case 4, an oral swab sample was supposedly taken after death but could not be found for retrospective testing. Despite characteristic symptomatology, case 5 was not identified as a suspect case for as long as 3 weeks. In epidemic contexts, health systems must be able to track all samples of suspect cases and deaths, regardless of their laboratory results. Social mobilization in communities and training in health care facilities must be strengthened at the tail of an outbreak, to avoid the natural slackening of disease surveillance, in particular for long-lasting and deadly epidemics.Keywords
This publication has 13 references indexed in Scilit:
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)The Lancet, 2017
- Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 DaysClinical Infectious Diseases, 2016
- Notes from The Field: Ebola Virus Disease Cluster — Northern Sierra Leone, January 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Molecular Evidence of Sexual Transmission of Ebola VirusNew England Journal of Medicine, 2015
- Social Vulnerability and Ebola Virus Disease in Rural LiberiaPLOS ONE, 2015
- Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort studyThe Lancet Infectious Diseases, 2015
- ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation studyThe Lancet, 2015
- Initiation of a Ring Approach to Infection Prevention and Control at Non-Ebola Health Care Facilities — Liberia, January–February 20152015
- Laboratory diagnosis of Ebola virus diseaseIntensive Care Medicine, 2015
- Evidence for a Decrease in Transmission of Ebola Virus — Lofa County, Liberia, June 8–November 1, 20142014